Comparing Empagliflozin / Linagliptin vs Ertugliflozin / Sitagliptin
Empagliflozin / linagliptin | Ertugliflozin / sitagliptin |
|
---|
Empagliflozin / linagliptin | Ertugliflozin / sitagliptin |
|
---|---|---|
Prescription only
Prescribed for Type 2 Diabetes. Empagliflozin / linagliptin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Type 2 Diabetes. Ertugliflozin / sitagliptin may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
|
More about Empagliflozin / linagliptin | More about Ertugliflozin / sitagliptin | |
Ratings & Reviews | ||
Empagliflozin / linagliptin has an average rating of 6.7 out of 10 from a total of 23 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 26% reported a negative effect. |
Ertugliflozin / sitagliptin has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
Drug Class | ||
Generic Availability | ||
N/A |
N/A |
|
Pricing and Coupons * Prices are without insurance | ||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | ||
N/A |
N/A |
|
Brand Names | ||
Glyxambi | Steglujan | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
12.4 hours |
16.6 hours |
|
CSA Schedule 1 View glossary of CSA terms | ||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | ||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
Drug Interactions | ||
A total of 486 drugs are known to interact with Empagliflozin / linagliptin:
|
A total of 403 drugs are known to interact with Ertugliflozin / sitagliptin:
|
|
Alcohol/Food/Lifestyle Interactions | ||
|
|
|
Disease Interactions | ||
First Approval Date | ||
January 30, 2015 |
December 19, 2017 |
|
WADA Class View classifications | ||
N/A |
N/A |
|
More Information | ||
Patient Resources | ||
Professional Resources | ||
N/A |
N/A |
|
Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.